Table of Contents Author Guidelines Submit a Manuscript
Journal of Transplantation
Volume 2014 (2014), Article ID 171898, 8 pages
http://dx.doi.org/10.1155/2014/171898
Clinical Study

Three-Year Outcomes in Kidney Transplant Patients Randomized to Steroid-Free Immunosuppression or Steroid Withdrawal, with Enteric-Coated Mycophenolate Sodium and Cyclosporine: The Infinity Study

1Service de Néphrologie, Hémodialyse et Transplantation Rénale, Hôpital La Milétrie, et INSERM U927, CHU, 86021 Poitiers, France
2Service de Néphrologie et Transplantation Rénale, Hôpital Lapeyronie, 371 rue du Doyen Gaston Giraud, 34295 Montpellier, France
3Service de Transplantation Rénale, CHU Bretonneau, 2, Boulevard Tonnellé, 37044 Tours Cedex, France
4Service de Néphrologie, Médecine Interne, Dialyse, Transplantation Rénale et Réanimation, Hôpital Sud, Avenue Laënnec, 80054 Amiens Cedex 1, France
5CHU Amiens et INSERM ERI-12, Université Jules Verne Picardie, Chemin du Thil, 80000 Amiens, France
6Service de Néphrologie et Transplantation Rénale, Hôpital Maison Blanche, 45 rue Cognacq Jay, 51092 Reims Cedex, France
7Service de Néphrologie-Transplantation, Hôpital de Rangueil, 1 rue Jean Poulhès, 31403 Toulouse Cedex 4, France
8Service de Néphrologie, CHU Angers, 4 rue Larrey, 49033 Angers, France
9Service de Néphrologie et Transplantation Rénale, Hôpital La Cavale Blanche, Boulevard Tanguy Prigent, 29200 Brest, France
10Service de Néphrologie et Transplantation Rénale, Hôpital Necker, 161 rue de Sèvres, 75015 Paris, France
11Service de Néphrologie et Transplantation Rénale, Hôpital Pellegrin, Place Amélie Raba Léon, 33076 Bordeaux, France
12Service de Néphrologie et Transplantation Rénale, CHU de Nancy, rue du Morvan, 54511 Vandoeuvre les Nancy, France
13Service de Néphrologie, Hôpital Gabriel Montpied, rue Montalembert, 63003 Clermont Ferrand Cedex 1, France
14Clinique Médicale B, Hôpital Civil, 1 Place de l’Hôpital, 67091 Strasbourg Cedex, France
15Unité Immuno-Transplantation, Novartis Pharma SAS, rue Lionel Terray, 92500 Rueil-Malmaison, France

Received 21 October 2013; Revised 4 January 2014; Accepted 6 January 2014; Published 5 March 2014

Academic Editor: Bruce Kaplan

Copyright © 2014 A. Thierry et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. F. L. Luan, D. E. Steffick, and A. O. Ojo, “Steroid-free maintenance immunosuppression in kidney transplantation: is it time to consider it as a standard therapy,” Kidney International, vol. 76, no. 8, pp. 825–830, 2009. View at Publisher · View at Google Scholar · View at Scopus
  2. F. Vincenti, F. P. Schena, S. Paraskevas, I. A. Hauser, R. G. Walker, and J. Grinyo, “A randomized, multicenter study of steroid avoidance, early steroid withdrawal or standard steroid therapy in kidney transplant recipients,” American Journal of Transplantation, vol. 8, no. 2, pp. 307–316, 2008. View at Publisher · View at Google Scholar · View at Scopus
  3. F. Vincenti, A. Monaco, J. Grinyo, M. Kinkhabwala, and A. Roza, “Multicenter randomized prospective trial of steroid withdrawal in renal transplant recipients receiving basiliximab, cyclosporine microemulsion and mycophenolate mofetil,” American Journal of Transplantation, vol. 3, no. 3, pp. 306–311, 2003. View at Publisher · View at Google Scholar · View at Scopus
  4. L. Rostaing, D. Cantarovich, G. Mourad et al., “Corticosteroid-free immunosuppression with tacrolimus, mycophenolate mofetil, and daclizumab induction in renal transplantation,” Transplantation, vol. 79, no. 7, pp. 807–814, 2005. View at Publisher · View at Google Scholar · View at Scopus
  5. M. S. Anil Kumar, S.-G. Xiao, B. Fyfe et al., “Steroid avoidance in renal transplantation using basiliximab induction, cyclosporine-based immunosuppression and protocol biopsies,” Clinical Transplantation, vol. 19, no. 1, pp. 61–69, 2005. View at Publisher · View at Google Scholar · View at Scopus
  6. O. A. Gheith, A. H. Nematalla, M. A. Bakr, A. Refaie, A. A. Shokeir, and M. A. Ghoneim, “Cost-benefit of steroid avoidance in renal transplant patients: a prospective randomized study,” Scandinavian Journal of Urology and Nephrology, vol. 44, no. 3, pp. 175–182, 2010. View at Publisher · View at Google Scholar · View at Scopus
  7. C. Sommerer, P. Glander, W. Arns et al., “Safety and efficacy of intensified versus standard dosing regimens of enteric-coated mycophenolate sodium in de novo renal transplant patients,” Transplantation, vol. 91, no. 7, pp. 779–785, 2011. View at Publisher · View at Google Scholar · View at Scopus
  8. S. Gourishankar, I. Houde, P. A. Keown et al., “The CLEAR study: a 5-day, 3-g loading dose of mycophenolate mofetil versus standard 2-g dosing in renal transplantation,” Clinical Journal of the American Society of Nephrology, vol. 5, no. 7, pp. 1282–1289, 2010. View at Publisher · View at Google Scholar · View at Scopus
  9. A. Thierry, G. Mourad, M. Büchler et al., “Steroid avoidance with early intensified dosing of enteric-coated mycophenolate sodium: a randomized, multicentre trial in kidney transplant recipients,” Nephrology Dialysis Transplantation, vol. 27, no. 9, pp. 3651–3659, 2012. View at Google Scholar
  10. J. M. M. Boots, M. H. L. Christiaans, and J. P. van Hooff, “Effect of immunosuppressive agents on long-term survival of renal transplant recipients: focus on the cardiovascular risk,” Drugs, vol. 64, no. 18, pp. 2047–2073, 2004. View at Publisher · View at Google Scholar · View at Scopus
  11. H. Pilmore, H. Dent, S. Chang, S. P. McDonald, and S. J. Chadban, “Reduction in cardiovascular death after kidney transplantation,” Transplantation, vol. 89, no. 7, pp. 851–857, 2010. View at Publisher · View at Google Scholar · View at Scopus
  12. F. Berthoux and C. Mariat, “Cardiovascular death after renal transplantation remains the first cause despite significant quantitative and qualitative changes,” Transplantation, vol. 89, no. 7, p. 806, 2010. View at Publisher · View at Google Scholar · View at Scopus
  13. J. Pascual, J. Zamora, C. Galeano, A. Royuela, and C. Quereda, “Steroid avoidance or withdrawal for kidney transplant recipients,” Cochrane Database of Systematic Reviews, no. 1, Article ID CD005632, 2009. View at Google Scholar · View at Scopus
  14. L. C. Cendales, J. Kanitakis, S. Schneeberger et al., “The Banff 2007 working classification of skin-containing composite tissue allograft pathology,” American Journal of Transplantation, vol. 8, no. 7, pp. 1396–1400, 2008. View at Publisher · View at Google Scholar · View at Scopus
  15. E. D. Poggio, X. Wang, D. M. Weinstein et al., “Assessing glomerular filtration rate by estimation equations in kidney transplant recipients,” American Journal of Transplantation, vol. 6, no. 1, pp. 100–108, 2006. View at Publisher · View at Google Scholar · View at Scopus
  16. D. W. Cockcroft and M. H. Gault, “Prediction of creatinine clearance from serum creatinine,” Nephron, vol. 16, no. 1, pp. 31–41, 1976. View at Google Scholar · View at Scopus
  17. B. J. Nankivell, S. M. Gruenewald, R. D. M. Allen, and J. R. Chapman, “Predicting glomerular filtration rate after kidney transplantation,” Transplantation, vol. 59, no. 12, pp. 1683–1689, 1995. View at Google Scholar · View at Scopus
  18. H. Ekberg, H. Tedesco-Silva, A. Demirbas et al., “Reduced exposure to calcineurin inhibitors in renal transplantation,” The New England Journal of Medicine, vol. 357, no. 25, pp. 2562–2575, 2007. View at Publisher · View at Google Scholar · View at Scopus
  19. H. T. Silva Jr., D. Cibrik, T. Johnston et al., “Everolimus plus reduced-exposure CsA versus mycophenolic acid plus standard-exposure CsA in renal-transplant recipients,” American Journal of Transplantation, vol. 10, no. 6, pp. 1401–1413, 2010. View at Publisher · View at Google Scholar · View at Scopus
  20. J. Pascual, J. P. Van Hooff, K. Salmela, P. Lang, P. Rigotti, and K. Budde, “Three-year observational follow-up of a multicenter, randomized trial on tacrolimus-based therapy with withdrawal of steroids or mycophenolate mofetil after renal transplant,” Transplantation, vol. 82, no. 1, pp. 55–61, 2006. View at Publisher · View at Google Scholar · View at Scopus
  21. D. M. Poetker and D. D. Reh, “A comprehensive review of the adverse effects of systemic corticosteroids,” Otolaryngologic Clinics of North America, vol. 43, no. 4, pp. 753–768, 2010. View at Publisher · View at Google Scholar · View at Scopus
  22. M. D. Rizzari, T. M. Suszynski, K. J. Gillingham et al., “Ten-year outcome after rapid discontinuation of prednisone in adult primary kidney transplantation,” Clinical Journal of the American Society of Nephrology, vol. 7, no. 3, pp. 494–503, 2012. View at Publisher · View at Google Scholar · View at Scopus